Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: Sept. 23, 2022
Immune-mediated
inflammatory
diseases(IMIDs)
are
referred
to
as
highly
disabling
chronic
diseases
affecting
different
organs
and
systems.
Inappropriate
or
excessive
immune
responses
with
inflammation
typical
manifestations.
Usually
in
patients
infection
cancer,
due
long-term
exposure
persistent
antigens
microenvironment,
T-cells
continuously
stimulated
gradually
differentiate
into
an
exhausted
state.
Exhausted
lose
effector
function
characteristics
of
memory
T-cells.
However,
existing
studies
have
found
that
not
only
present
the
tumor
environment,
but
also
autoimmunity,
associated
better
prognosis
IMIDs.
This
suggests
new
prospects
for
application
this
reversible
process
T-cell
exhaustion
treatment
IMID.
review
will
focus
on
research
progress
several
IMIDs
its
potential
diagnosis
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: April 22, 2024
Abstract
Systemic
lupus
erythematosus
(SLE)
is
an
autoimmune
disease
characterized
by
anti-nuclear
autoantibodies
whose
production
promoted
autoreactive
T
follicular
helper
(TFH)
cells.
During
SLE
pathogenesis,
basophils
accumulate
in
secondary
lymphoid
organs
(SLO),
amplify
autoantibody
and
progression
through
mechanisms
that
remain
to
be
defined.
Here,
we
provide
evidence
for
a
direct
functional
relationship
between
TFH
cells
during
both
humans
mice.
PD-L1
upregulation
on
IL-4
are
associated
with
TFH2
cell
expansions
activity.
Pathogenic
accumulation,
maintenance,
function
SLO
were
dependent
basophils,
which
induced
transcriptional
program
allowing
differentiation
function.
Our
study
establishes
mechanistic
link
promotes
nephritis.
Cell Reports Medicine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 101974 - 101974
Published: Feb. 1, 2025
Pregnancy
disorders
in
patients
with
autoimmune
diseases
or
viral
infections
are
often
associated
an
excessive
response
of
type
I
interferons.
We
identify
radical
S-adenosyl
methionine
domain
containing
2
(RSAD2)
as
a
pathogenic
interferon-stimulated
gene
(ISG)
pregnancy
complications
systemic
lupus
erythematosus
(SLE).
The
increased
expression
RSAD2
mainly
occurs
macrophages
and
structural
cell
populations
at
the
maternal-fetal
interface
pregnant
SLE.
elevation
leads
to
accumulation
diacylglycerol
lipids
placenta,
impairing
necessary
vascular
development
for
fetus.
Depletion
Rsad2
mice
models
exposed
interferon
inducers
significantly
reduces
lipid
accumulation,
injury,
embryo
disorders.
An
inhibitor,
L-chicoric
acid
(LCA),
alleviates
damage,
improving
outcomes
SLE-induced
spontaneous
mouse
models.
This
study
proposes
potential
targeting
improve
individuals
heightened
response.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 24, 2025
Abstract
Endosomal
nucleic
acid
sensing
by
Toll-like
receptors
(TLRs)
is
central
to
antimicrobial
immunity
and
several
autoimmune
conditions
such
as
systemic
lupus
erythematosus
(SLE).
The
innate
immune
adaptor
TASL
mediates,
via
the
interaction
with
SLC15A4,
activation
of
IRF5
downstream
human
TLR7,
TLR8
TLR9,
but
pathophysiological
functions
this
axis
remain
unexplored.
Here
we
show
that
SLC15A4
deficiency
results
in
a
selective
block
TLR7/9-induced
activation,
while
loss
leads
strong
incomplete
impairment,
which
depends
on
cell
type
TLR
engaged.
This
residual
activity
ascribed
previously
uncharacterized
paralogue,
Gm6377
,
named
here
TASL2.
Double
knockout
TASL2
(TASL
DKO
)
phenocopies
SLC15A4-deficient
feeble
mice
showing
comparable
impairment
humoral
responses.
Consequently,
fail
control
chronic
LCMV
infection,
being
protected
pristane-induced
SLE
disease
model.
Our
study
thus
demonstrates
critical
role
TASL/TASL2
for
TLR7/9-driven
inflammatory
responses,
further
supporting
therapeutic
potential
targeting
complex
related
diseases.
Journal of the American Chemical Society,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 11, 2025
Immune
disorders
induced
by
cell-free
DNA
(cfDNA)
account
for
the
incidence
and
deterioration
of
systemic
lupus
erythematosus
(SLE).
Scavenging
cfDNA
using
cationic
polymers
represents
a
promising
modality
SLE
management.
However,
they
bind
mainly
via
electrostatic
interaction,
which
would
result
in
an
undesired
discharge
captured
upon
competitive
replacement
negatively
charged
serum/intracellular
components.
Inspired
natural
recognition
mechanism
biomacromolecules
spatial
matching,
we
herein
developed
library
dendrimer-templated,
spherical,
α-helical,
guanidine-rich
polypeptides
as
molecular
clips
scavenging.
Upon
optimization
polypeptide
length
density
on
dendrimer
surface,
top-performing
G3-8
was
identified,
could
tightly
confine
within
cavity
between
adjacent,
rod-like
α-helices.
As
thus,
helical
but
not
random-coiled
analogue
D,L-G3-8
enabled
robust
scavenging
under
serum-rich
conditions
to
inhibit
TLR9
activation
inflammation.
In
mice,
i.v.
injected
efficiently
prevented
organ
failure
inhibited
inflammation
cfDNA.
This
study
provides
enlightened
strategy
stably
scavenge
may
shift
current
paradigm
Science Translational Medicine,
Journal Year:
2025,
Volume and Issue:
17(786)
Published: Feb. 19, 2025
Systemic
lupus
erythematosus
(SLE)
is
characterized
by
dysfunctional
regulatory
T
cells
(T
regs
).
We
previously
showed
that
protein
phosphatase
2A
(PP2A)
plays
a
critical
role
in
maintaining
the
suppressive
function
of
.
Here,
we
analyzed
phosphoproteomics
and
metabolomics
data
from
PP2A–wild
type
PP2A-deficient
demonstrated
PP2A
regulates
reg
through
pentose
phosphate
pathway
(PPP).
Furthermore,
proved
PPP
metabolite
gluconolactone
(GDL)
enhances
vitro
induced
(i)T
differentiation
promoting
forkhead
box
3
phosphorylated
signal
transducer
activator
transcription
5
expression
inhibits
helper
17
H
17)
murine
cells.
In
short-term
imiquimod-induced
autoimmunity
mice,
treatment
with
GDL
alleviates
inflammation
inhibiting
promotes
skin
lesions
MRL.
lpr
lupus-prone
mice
vivo.
It
also
ex
vivo
experiments
using
patients
SLE.
Last,
suffering
cutaneous
erythematosus,
topical
application
GDL-containing
cream
controlled
improved
clinical
histologic
appearance
within
2
weeks.
Together,
have
identified
as
mechanistically
it
restores
immune
regulation
inducing
should
be
considered
approach
for
inflammatory
autoimmune
diseases.
Journal of Interferon & Cytokine Research,
Journal Year:
2021,
Volume and Issue:
41(11), P. 391 - 406
Published: Nov. 1, 2021
The
balance
between
inflammatory
and
anti-inflammatory
immune
responses
is
maintained
through
immunoregulatory
cell
populations
immunosuppressive
cytokines.
Interleukin-35
(IL-35),
an
inhibitory
cytokine
that
belongs
to
the
IL-12
family,
capable
of
potently
suppressing
T
proliferation
inducing
IL-35-producing
induced
regulatory
cells
(iTr35)
limit
responses.
Over
past
decade,
a
growing
number
studies
have
indicated
IL-35
plays
important
role
in
controlling
immune-related
disorders,
including
autoimmune
diseases,
infectious
cancer.
In
this
review,
we
summarize
current
knowledge
about
biology
its
contribution
different
discuss
potential
barriers
harnessing
as
clinical
biomarker
or
immunotherapy.
Frontiers in Immunology,
Journal Year:
2021,
Volume and Issue:
12
Published: April 26, 2021
Toll-like
receptors
(TLRs)
are
important
initiators
of
the
immune
response,
both
innate
and
acquired.
Evidence
suggests
that
gene
polymorphisms
within
TLRs
cause
malfunctions
certain
key
TLR-related
signaling
pathways,
which
subsequently
increases
risk
autoimmune
diseases.
We
illustrate
discuss
current
findings
on
role
receptor
in
numerous
diseases
this
review,
such
as
type
1
diabetes
mellitus,
Graves’
disease,
rheumatoid
arthritis,
systemic
lupus
erythematosus
multiple
sclerosis.
The
study
genetic
variation
different
populations
has
shown
a
complex
interaction
between
immunity
environmental
factors.
This
TLR
affect
susceptibility
to
differently
various
populations.
identification
can
expand
our
understanding
pathogenesis
diseases,
will
guide
effective
medical
management
provide
insight
into
prognosis
advanced
treatments.